Pinsent Masons climbs Stonewall Workplace Equality Index

17 Jan 2013 | 09:19 am |

International law firm Pinsent Masons has again cemented its reputation for commitment to diversity in the latest Stonewall Workplace Equality Index. It is the sixth year in a row that the firm has been included in the list, the longest of any law firm.

Pinsent Masons was ranked 22nd in the top 100 lesbian, gay and bisexual-friendly employers in the UK, 19 places higher than the previous year, and was the third highest law firm included in the rankings. In addition our LGBT Network Group was named as one of Stonewall’s Star Performer Network Groups. 

Speaking on the results, Jonathan Bond, Director of HR and Learning at Pinsent Masons said, "The firm is constantly promoting an inclusive culture that encourages everyone to be themselves at work and realise their full potential. Ranking in the Top 100 once again is a great result that reflects the continued progress we have made in promoting equality and diversity."

For more information about the Stonewall Workplace Equality Index, go to www.stonewall.org.uk

Latest press releases

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts